ClinicalTrials.Veeva

Menu

Prospective Evaluation of 14F Thal Tube vs 28 French Chest Tube for Hemothorax and Use of Maximum Barrier Precautions

Wake Forest University (WFU) logo

Wake Forest University (WFU)

Status

Completed

Conditions

Hemothorax
Hemopneumothorax; Traumatic
Empyema
Chest Tube Size

Treatments

Device: Chest tube placement

Study type

Interventional

Funder types

Other

Identifiers

NCT03167723
Pro00020984 (Other Identifier)
IRB00081328

Details and patient eligibility

About

Traumatic hemothorax and hemopneumothorax are common diagnoses which are typically treated by placement of a chest tube. 28-32 Fr chest tubes have previously been shown equivalent to 36-40 Fr chest tubes for the non-emergent drainage of hemothorax. A smaller study has found 14 Fr pigtails had less pain than larger tubes but was not powered to compare outcomes. We seek to perform a prospective randomized trial that is adequately powered comparing efficacy of 14 Fr thal tubes to 28 Fr chest tubes for non-emergent drainage of hemothorax and hemopneumothorax. Additionally, we will employ maximal barrier precautions for all chest tube insertions and compare empyema rates to our historical controls.

Enrollment

193 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • The patient is admitted to the trauma service.
  • The patient has a hemothorax and/or or hemopneumothorax, requiring thoracostomy tube placement.
  • Thoracostomy tube placement is able to be performed or witnessed by an investigator listed on the study.
  • The patient has not had a chest tube in the past year.
  • The patient is >18 years of age.
  • In the event the patient is decisionally impaired, consent will be obtained from the individual's legally authorized representative (LAR) or from the individual's healthcare power of attorney (HPA).
  • In the instance of reversible impairment, initial consent would be obtained from the LAR/HPA and the patient will be approached for consent once he/she is deemed mentally competent by the care provider.

Exclusion criteria

  • The patient is incarcerated
  • The patient is known to be pregnant
  • The patient is < 18 years of age
  • The patient is hemodynamically unstable, requiring emergent chest tube placement (in <10 minutes from evaluation).

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

193 participants in 2 patient groups

28 French chest tube for hemothorax
Experimental group
Description:
28 French straight chest tube placed for non-emergent drainage of hemothorax or hemopneumothorax
Treatment:
Device: Chest tube placement
14 French chest tube for hemothorax
Experimental group
Description:
14 French thal chest tube placed for non-emergent drainage of hemothorax or hemopneumothorax
Treatment:
Device: Chest tube placement

Trial documents
2

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems